Protein inhibitors to complement and VEGF pathways and methods of use thereof
The invention provides bispecific fusion proteins that inhibit activation of complement pathway and vascular endothelial growth factor (VEGF) pathway and methods for using these fusion proteins.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
06.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides bispecific fusion proteins that inhibit activation of complement pathway and vascular endothelial growth factor (VEGF) pathway and methods for using these fusion proteins. |
---|---|
Bibliography: | Application Number: US201815965382 |